YAKHAK HOEJI (약학회지)

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Effect of Antimicrobial Peptide from Coptidis Rhizoma on Candida albicans Infection

황련 유래 Antimicrobial Peptide의 Candida albicans 감염 억제효과

  • Lee, Jue-Hee (School of Korean Medicine, Pusan University)
  • 이주희 (부산대학교 한의학 전문대학원)
  • Received : 2011.04.14
  • Accepted : 2011.05.12
  • Published : 2011.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

We previously reported the protein isolated from Coptidis Rhizoma (CRP), which has antifungal activity against a fungal pathogen, Candida albicans. In the current study, we investigated what portion in the CRP is responsible for the antifungal activity. For the investigation, the CRP was fractionated on a Shepadex G-50 column. Data resulting from the fractionation, seven fractions were obtained. Fractions (Fr.) I, II, and III eluted initially from the column showed no inhibitory effect on the growth of C. albicans, whereas Fr. IV, V, and VI eluted later revealed inhibition of the growth, and Fr. IV and VI showed potent antifungal activity by broth susceptibility analysis. However, Fr. VI was contained in the CRP more than Fr. IV, which led us to select the VI for the following experiments. In a murine model of a subcutaneous candidiasis caused by C. albicans, the Fr. VI displayed a therapeutic effect on nude mice pretreated with anti-neutrophil monoclonal antibody (RB68C5) and then infected subcutaneously with live C. albicans. At day 16, these mice were healed almost up to 78% of the infected area when compared to infected area of control nude mice that received diluent (Dulbecco's Phosphate-Buffered Saline; DPBS), instead of the Fr. VI (P<0.01). The Fr. VI blocked hyphal formation from blastoconidial form of C. albicans (P<0.01), which might prevent penetration of hyphae to the deeper site of skin and thus helps the healing. In the ionic strength test, the effect of Fr. was influenced by $Ca^{2+}$ ion just like other known antimicrobial peptides, but the influence was affected at an extremely high concentration such as 500 mM. Thus, such ion-concentration is considered to be meaningless in the clinical situation. Considering all data together, Coptidis Rhizoma is appeared to produce an antimicrobial peptide that has therapeutic effect on subcutaneous infection caused by C. albicans.

Keywords

References

  1. Danilova, N. : The evolution of immune mechanisms. J. Exp. Zool. 306B, 496 (2006). https://doi.org/10.1002/jez.b.21102
  2. Desgagné-Penix, I., Khan, M. F., Schriemer, D. C., Cram, D., Nowak, J. and Facchini, P. J. : Integration of deep transcriptome and proteome analyses reveals the components of alkaloid metabolism in opium poppy cell cultures. BMC Plant Biol. 10, 252 (2010). https://doi.org/10.1186/1471-2229-10-252
  3. Dzik, J. M. : The ancestry and cumulative evolution of immune reactions. Acta Biochim. Pol. 57, 443 Epub (2010).
  4. Bulet, P., Stocklin, R. and Menin, L. : Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198, 169 (2004). https://doi.org/10.1111/j.0105-2896.2004.0124.x
  5. Zasloff, M. : Antimicrobial peptides of multicellular organisms. Nature 415, 389 (2002). https://doi.org/10.1038/415389a
  6. Lee, D. G., Park, Y., Kim, H. N., Kim, H. K., Kim, P. I., Choi, B. H. and Hahm, K. S. : Antifungal mechanism of an antimicrobial peptide, HP (2--20), derived from N-terminus of Helicobacter pylori ribosomal protein L1 against Candida albicans. Biochem. Biophys. Res. Commun. 291, 1006 (2002). https://doi.org/10.1006/bbrc.2002.6548
  7. Fleury, Y., Dayem, M. A., Montagne, J. J., Chaboisseau, E., Le Caer, J. P., Nicolas, P. and Delfour, A. : Covalent structure, synthesis, and structure-function studies of mesentericin Y 105(37), a defensive peptide from gram-positive bacteria Leuconostoc mesenteroides. J. Biol. Chem. 271, 14421 (1996). https://doi.org/10.1074/jbc.271.24.14421
  8. Brogden, K. A. : Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238 (2005). https://doi.org/10.1038/nrmicro1098
  9. Broekaert, W. F., Terras, F. R., Cammue, B. P. and Osborn, R. W. : Plant defensins: novel antimicrobial peptides as components of the host defense system. Plant Physiol. 108, 1353 (1995). https://doi.org/10.1104/pp.108.4.1353
  10. Kim, H., Lee, J. H., Shim, J. K. and Han, Y. : Anticandidal activity of the protein substance from Coptidis Rhizoma. Yakhak Hoeji 49, 323 (2005).
  11. Lee, J. H., Shim, J. K. and Han, Y. : Mode of action of Coptidis Rhizoma protein and its activity against subcutaneous candidiasis due to Candida albicans. Anticandidal activity of the protein substance from Coptidis Rhizoma. Yakhak Hoeji 49, 422 (2005).
  12. Wisplinghoff, H., Bischoff, T., Tallent, S. M., Seifert, H., Wenzel, R. P. and Edmond, M. B. : Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin. Infect. Dis. 39, 309 (2004). https://doi.org/10.1086/421946
  13. Perfect, J. R. and Schell, W. A. : The new fungal opportunists are coming. Clin. Infect. Dis. 22, S112 (1996). https://doi.org/10.1093/clinids/22.Supplement_2.S112
  14. Villar, C. C., Kashleva, H. and Dongari-Bagtzoglou, A. : Role of Candida albicans polymorphism in interactions with oral epithelial cells. Oral Microbiol. Immunol. 19, 262 (2004). https://doi.org/10.1111/j.1399-302X.2004.00150.x
  15. Vazquez-Torres, A. and Balish, E. : Macrophages in resistance to candidiasis. Microbiol. Mol. Biol. Rev. 61, 170 (1997).
  16. Ashman, R. B. and Papadimitriou, J. M. : What's new in the mechanisms of host resistance to Candida albicans infection? Pathol. Res. Pract. 186, 527 (1990). https://doi.org/10.1016/S0344-0338(11)80477-2
  17. Leberer, E., Ziegelbaue, R. K., Schmidt, A., Harcus, D., Dignard, D., Ash, J., Johnson, L. and Thomas, D. Y. : Curr. Biol. 7, 539 (1997). https://doi.org/10.1016/S0960-9822(06)00252-1
  18. Phan, Q. T., Belanger, P. H. and Filler, S. G. : Role of hyphal formation in interactions of Candida albicans with endothelial cells. Infect. Immun. 68, 3485 (2000). https://doi.org/10.1128/IAI.68.6.3485-3490.2000
  19. Cutler, J. E., Granger, B. L. and Han, Y. : Vaccines, antibodies, and passive immunity in candidiasis. In: Fungal Pathogenesis. Principles and clinical application. (Ed) Calderone R. A. and Cihlar R. A. Marcel Dekker, Inc. New York. Mycology 14, 325 (2002).
  20. Cutler, J. E. : Putative virulence factors of Candida albicans. Ann. Rev. Microbiol. 45, 187 (1991). https://doi.org/10.1146/annurev.mi.45.100191.001155
  21. Jutila, M. A., Kroese, F. G. M., Julita, K. L., et al. : Ly-6C is a monocyte/macrophage and endothelial cell differentiation antigen regulated by interferon-gamma. Eur. J. Immunol. 18, 1819 (1998).
  22. Fleming, T. J., Fleming, M. L. and Malek, T. R. : Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 Mab to granulocyte-differentiation antigen (Gr-1)detects members of the Ly-6 family. J. Immunol. 151, 2399 (1993).
  23. Jutila, M. A., Kishimoto, T. K. and Finken, M. : Low-dose chymotrypsin treatment inhibits neutriohil migration into sites of inflammation in vivo: effects on Mac-1 and MEL-14 adhesion protein expression and function. Cell Immunol. 132, 201 (1991). https://doi.org/10.1016/0008-8749(91)90019-8
  24. Czuprynski, C. J., Brown, J. F., Maroushek, N., Wagner, R. D. and Steinberg, H. : Administration of anti-granulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol. 152, 1836 (1994).
  25. Pekarek, L. A., Starr, B. A., Toledano, A. Y. and Schreiber, H. : Inhibition of tumor growth by elimination of granulocytes. J. Exp. Med. 181, 435 (1995). https://doi.org/10.1084/jem.181.1.435
  26. Han, Y. and Cutler, J. E. : Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis. 175, 1169 (1997). https://doi.org/10.1086/516455
  27. Han, Y. and Lee, J. H. : Berberine synergy with amphotericin B against disseminated candiasis in mice. Biol. Pharm. Bull. 28, 541 (2005). https://doi.org/10.1248/bpb.28.541